XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues:      
Total revenues $ 2,986,267 $ 2,666,702 $ 2,158,759
Costs and expenses:      
Cost of product revenues (including definite-lived intangible amortization) 150,991 131,328 114,249
Research and development 1,458,179 2,215,942 1,154,111
Selling, general and administrative 739,560 516,922 468,711
Change in fair value of acquisition-related contingent consideration 14,741 23,385 19,682
Collaboration loss sharing 37,019 42,801  
Total costs and expenses 2,400,490 2,930,378 1,756,753
Income (loss) from operations 585,777 (263,676) 402,006
Other income (expense), net 10,647 23,206 52,182
Interest expense (1,908) (2,174) (1,855)
Unrealized (loss) gain on long term investments (24,072) 10,426 34,458
Income (loss) before (benefit) provision for income taxes 570,444 (232,218) 486,791
(Benefit) provision for income taxes (378,137) 63,479 39,885
Net income (loss) $ 948,581 $ (295,697) $ 446,906
Net income (loss) per share:      
Basic $ 4.30 $ (1.36) $ 2.08
Diluted $ 4.27 $ (1.36) $ 2.05
Shares used in computing net income (loss) per share:      
Basic 220,428 218,073 214,913
Diluted 222,074 218,073 217,657
Product revenues, net      
Revenues:      
Total revenues $ 2,322,012 $ 2,068,736 $ 1,774,922
Product royalty revenues      
Revenues:      
Total revenues 569,255 392,966 306,337
Milestone and contract revenues      
Revenues:      
Total revenues $ 95,000 $ 205,000 $ 77,500